Related Experiment Video
Updated: Apr 14, 2026
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
14.3K
Statin intolerance: diagnosis and remedies
Angela Pirillo1, Alberico Luigi Catapano
1Center for the Study of Atherosclerosis, E. Bassini Hospital, Via M. Gorki 50, Cinisello Balsamo, Milan, Italy, angela.pirillo@guest.unimi.it.
Current Cardiology Reports
|April 21, 2015
Summary
Statin intolerance due to muscle adverse effects impacts adherence. Alternative therapies offer options for patients needing cardiovascular risk reduction, with ongoing trials assessing their long-term benefits.
Area of Science:
- Cardiology
- Pharmacology
- Genetics
Background:
- Statins are effective in reducing cardiovascular events for primary and secondary prevention.
- Suboptimal adherence to statin therapy is a significant clinical challenge, primarily due to muscular adverse effects (myotoxicity).
- Factors influencing statin-induced myotoxicity include patient characteristics, statin properties, and drug interactions.
Purpose of the Study:
- To review the management strategies for patients experiencing statin intolerance.
- To explore alternative lipid-lowering therapies for high-risk cardiovascular patients unable to tolerate statins.
- To highlight emerging hypolipidemic agents and ongoing research into their cardiovascular benefits.
Main Methods:
- Literature review of studies on statin efficacy, adherence, and adverse effects.
- Analysis of risk factors contributing to statin-induced myotoxicity.
- Overview of current and novel therapeutic alternatives to statin therapy.
Main Results:
- Statin-induced myotoxicity is multifactorial, involving patient, drug, and interaction variables.
- Alternative management includes switching statins, intermittent dosing, or non-statin lipid-lowering drugs.
- Novel agents like PCSK9 inhibitors, mipomersen, and lomitapide offer new therapeutic avenues.
Conclusions:
- Effective management of statin intolerance is crucial for cardiovascular risk reduction.
- A range of alternative lipid-lowering strategies exist for patients intolerant to statins.
- Further clinical trials are necessary to confirm the cardiovascular benefits of these alternative therapies.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
01:26Atherosclerosis III: Management
603
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
603
01:26Angina IV: Management
441
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
441
01:26Peptic Ulcer Disease IV: Management
690
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
690
01:27Coronary Artery Disease V: Interprofessional Care
423
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
423
01:22Myocarditis IV: Nursing Management
369
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
369